关注
Clémence Cheignon
Clémence Cheignon
在 unistra.fr 的电子邮件经过验证
标题
引用次数
年份
Structure–Activity Optimization of Luminescent Tb-doped LaF3 Nanoparticles
MA Rahali, CL Heinritz, A Hagège, P Ronot, A Boos, LJ Charbonnière, ...
Inorganic Chemistry, 2024
2024
Exploitation of Luminescent Lanthanide Nanoparticles for a Sensitivity-Enhanced ELISA Detection Method
AA Kassir, C Cheignon, LJ Charbonnière
Analytical Chemistry 96 (5), 2107-2116, 2024
12024
Bioconjugation studies of an EGF-R targeting ligand on dendronized iron oxide nanoparticles to target head and neck cancer cells
B Freis, MDLÁ Ramírez, S Furgiuele, F Journe, C Cheignon, ...
International Journal of Pharmaceutics 635, 122654, 2023
72023
Oxidative Damages on the Alzheimer’s Related-Aβ Peptide Alters Its Ability to Assemble
C Cheignon, F Collin, L Sabater, C Hureau
Antioxidants 12 (2), 472, 2023
2023
Dye-sensitized lanthanide containing nanoparticles for luminescence based applications
C Cheignon, AA Kassir, LK Soro, LJ Charbonnière
Nanoscale 14 (38), 13915-13949, 2022
142022
Investigation of the Supramolecular Assembly of Luminescent Lanthanide Nanoparticles Surface Functionalized by p‐Sulfonato‐Calix[4]arenes with Charged …
C Cheignon, M Heurté, RC Knighton, AA Kassir, A Lecointre, A Nonat, ...
European Journal of Inorganic Chemistry 2021 (36), 3761-3770, 2021
72021
Cover Feature: Ultrabright Terbium Nanoparticles for FRET Biosensing and in Situ Imaging of Epidermal Growth Factor Receptors (Chem. Eur. J. 64/2020)
C Charpentier, V Cifliku, J Goetz, A Nonat, C Cheignon, ...
Chemistry–A European Journal 26 (64), 14505-14505, 2020
12020
Ultrabright terbium nanoparticles for FRET biosensing and in situ imaging of epidermal growth factor receptors
C Charpentier, V Cifliku, J Goetz, A Nonat, C Cheignon, ...
Chemistry–A European Journal 26 (64), 14602-14611, 2020
152020
Receptor–Ligand Interaction Measured by Inductively Coupled Plasma Mass Spectrometry and Selenium Labeling
C Cheignon, E Cordeau, N Prache, S Cantel, J Martinez, G Subra, ...
Journal of Medicinal Chemistry 61 (22), 10173-10184, 2018
162018
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
C Cheignon, M Tomas, D Bonnefont-Rousselot, P Faller, C Hureau, ...
Redox biology 14, 450-464, 2018
17892018
Real-time evolution of Aβ40 metal-catalyzed oxidation reveals Asp1 as the main target and a dependence on metal binding site
C Cheignon, C Hureau, F Collin
Inorganica Chimica Acta 472, 111-118, 2018
192018
Oxidative stress as a biomarker for Alzheimer’s disease
F Collin, C Cheignon, C Hureau
Biomarkers in Medicine 12 (3), 201-203, 2018
562018
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol 14: 450–464
C Cheignon, M Tomas, D Bonnefont-Rousselot, P Faller, C Hureau, ...
852018
Identification of key structural features of the elusive Cu–Aβ complex that generates ROS in Alzheimer’s disease
C Cheignon, M Jones, E Atrián-Blasco, I Kieffer, P Faller, F Collin, ...
Chemical science 8 (7), 5107-5118, 2017
1252017
Oxidation of the amyloid-beta peptide and consequences on the etiology of Alzheimer's disease
C Cheignon
Université Paul Sabatier-Toulouse III, 2016
12016
Metal-catalyzed oxidation of Aβ and the resulting reorganization of Cu binding sites promote ROS production
C Cheignon, P Faller, D Testemale, C Hureau, F Collin
Metallomics 8 (10), 1081-1089, 2016
672016
Metal-catalyzed oxidation of the Aβ peptide in Alzheimer’s Disease: characterization of oxidation sites and consequences on ROS production and copper coordination
C CHEIGNON, P FALLER, C HUREAU, F COLLIN
Casa Convalescència ALBA Synchrotron 7-10 June 2016 Barcelona, 13, 2016
2016
Is ascorbate Dr Jekyll or Mr Hyde in the Cu (Aβ) mediated oxidative stress linked to Alzheimer's disease?
C Cheignon, F Collin, P Faller, C Hureau
Dalton Transactions 45 (32), 12627-12631, 2016
392016
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease, Redox Biol. 14 (2018) 450–464
C Cheignon, M Tomas, D Bonnefont-Rousselot, P Faller, C Hureau, ...
22
CBC SEMINAR ANNOUNCEMENT
C Cheignon
系统目前无法执行此操作,请稍后再试。
文章 1–20